img

Global and United States Swine Epidemic Encephalitis Inactivated Vaccine Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Swine Epidemic Encephalitis Inactivated Vaccine Market Report & Forecast 2024-2034

Swine Epidemic Encephalitis Inactivated Vaccine is inoculated into the brains of mice with the porcine Japanese encephalitis virus HW1 strain, and the infected mouse brain tissue is harvested to make a suspension, which is inactivated by formaldehyde solution and emulsified with an adjuvant. For the prevention of porcine Japanese encephalitis.
Market Analysis and InsightsGlobal and United States Swine Epidemic Encephalitis Inactivated Vaccine Market
This report focuses on global and United States Swine Epidemic Encephalitis Inactivated Vaccine market, also covers the segmentation data of other regions in regional level and county level.
The global Swine Epidemic Encephalitis Inactivated Vaccine revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period (2024-2034).
In United States the Swine Epidemic Encephalitis Inactivated Vaccine revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Swine Epidemic Encephalitis Inactivated Vaccine include KM Biologics, Zoetis Animal Health, Boehringer-Ingelheim, Eurovet, Hipra, China Animal Husbandry Industry, Inyu Bio-technology, TECON and SPAH, etc. The global five biggest players hold a share of % in 2024.
Global Swine Epidemic Encephalitis Inactivated Vaccine Scope and Market Size
Swine Epidemic Encephalitis Inactivated Vaccine market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Swine Epidemic Encephalitis Inactivated Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For United States market, this report focuses on the Swine Epidemic Encephalitis Inactivated Vaccine market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


KM Biologics
Zoetis Animal Health
Boehringer-Ingelheim
Eurovet
Hipra
China Animal Husbandry Industry
Inyu Bio-technology
TECON
SPAH
Chongqing Auleon Biologicals
Wuhan Keqian Biology
Hunan Sinoland Bio-Pharmaceutical
MERRY
Shanghai Hile Bio-Technology
Guangdong Winsun Bio Pharmaceutical
Jinhe Biotechnology
Segment by Type
Mouse Brain Inactivated Vaccine
Cell Culture Inactivated Vaccine
Cell Culture Live Attenuated Vaccine
Genetically Engineered Live Attenuated Vaccine

Segment by Application


Piglets
Adults Pigs
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Swine Epidemic Encephalitis Inactivated Vaccine definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Swine Epidemic Encephalitis Inactivated Vaccine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Swine Epidemic Encephalitis Inactivated Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Swine Epidemic Encephalitis Inactivated Vaccine sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Swine Epidemic Encephalitis Inactivated Vaccine Product Introduction
1.2 Global Swine Epidemic Encephalitis Inactivated Vaccine Outlook 2018 VS 2024 VS 2034
1.2.1 Global Swine Epidemic Encephalitis Inactivated Vaccine Sales in US$ Million for the Year 2018-2034
1.2.2 Global Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume for the Year 2018-2034
1.3 United States Swine Epidemic Encephalitis Inactivated Vaccine Outlook 2018 VS 2024 VS 2034
1.3.1 United States Swine Epidemic Encephalitis Inactivated Vaccine Sales in US$ Million for the Year 2018-2034
1.3.2 United States Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume for the Year 2018-2034
1.4 Swine Epidemic Encephalitis Inactivated Vaccine Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of United States Swine Epidemic Encephalitis Inactivated Vaccine in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Swine Epidemic Encephalitis Inactivated Vaccine Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.5 Swine Epidemic Encephalitis Inactivated Vaccine Market Dynamics
1.5.1 Swine Epidemic Encephalitis Inactivated Vaccine Industry Trends
1.5.2 Swine Epidemic Encephalitis Inactivated Vaccine Market Drivers
1.5.3 Swine Epidemic Encephalitis Inactivated Vaccine Market Challenges
1.5.4 Swine Epidemic Encephalitis Inactivated Vaccine Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Swine Epidemic Encephalitis Inactivated Vaccine by Type
2.1 Swine Epidemic Encephalitis Inactivated Vaccine Market Segment by Type
2.1.1 Mouse Brain Inactivated Vaccine
2.1.2 Cell Culture Inactivated Vaccine
2.1.3 Cell Culture Live Attenuated Vaccine
2.1.4 Genetically Engineered Live Attenuated Vaccine
2.2 Global Swine Epidemic Encephalitis Inactivated Vaccine Market Size by Type
2.2.1 Global Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Swine Epidemic Encephalitis Inactivated Vaccine Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 United States Swine Epidemic Encephalitis Inactivated Vaccine Market Size by Type
2.3.1 United States Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 United States Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 United States Swine Epidemic Encephalitis Inactivated Vaccine Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Swine Epidemic Encephalitis Inactivated Vaccine by Application
3.1 Swine Epidemic Encephalitis Inactivated Vaccine Market Segment by Application
3.1.1 Piglets
3.1.2 Adults Pigs
3.2 Global Swine Epidemic Encephalitis Inactivated Vaccine Market Size by Application
3.2.1 Global Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Swine Epidemic Encephalitis Inactivated Vaccine Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 United States Swine Epidemic Encephalitis Inactivated Vaccine Market Size by Application
3.3.1 United States Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 United States Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 United States Swine Epidemic Encephalitis Inactivated Vaccine Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Swine Epidemic Encephalitis Inactivated Vaccine Competitor Landscape by Company
4.1 Global Swine Epidemic Encephalitis Inactivated Vaccine Market Size by Company
4.1.1 Global Key Manufacturers of Swine Epidemic Encephalitis Inactivated Vaccine, Ranked by Revenue (2024)
4.1.2 Global Swine Epidemic Encephalitis Inactivated Vaccine Revenue by Manufacturer (2018-2023)
4.1.3 Global Swine Epidemic Encephalitis Inactivated Vaccine Sales by Manufacturer (2018-2023)
4.1.4 Global Swine Epidemic Encephalitis Inactivated Vaccine Price by Manufacturer (2018-2023)
4.2 Global Swine Epidemic Encephalitis Inactivated Vaccine Concentration Ratio (CR)
4.2.1 Swine Epidemic Encephalitis Inactivated Vaccine Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Swine Epidemic Encephalitis Inactivated Vaccine in 2024
4.2.3 Global Swine Epidemic Encephalitis Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Swine Epidemic Encephalitis Inactivated Vaccine, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Swine Epidemic Encephalitis Inactivated Vaccine, Product Offered and Application
4.5 Global Key Manufacturers of Swine Epidemic Encephalitis Inactivated Vaccine, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Swine Epidemic Encephalitis Inactivated Vaccine Market Size by Company
4.7.1 Key Players of Swine Epidemic Encephalitis Inactivated Vaccine in United States, Ranked by Revenue (2024)
4.7.2 United States Swine Epidemic Encephalitis Inactivated Vaccine Revenue by Players (2018-2023)
4.7.3 United States Swine Epidemic Encephalitis Inactivated Vaccine Sales by Players (2018-2023)
5 Global Swine Epidemic Encephalitis Inactivated Vaccine Market Size by Region
5.1 Global Swine Epidemic Encephalitis Inactivated Vaccine Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Swine Epidemic Encephalitis Inactivated Vaccine Market Size in Volume by Region (2018-2034)
5.2.1 Global Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume by Region: 2018-2023
5.2.2 Global Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume Forecast by Region (2024-2034)
5.3 Global Swine Epidemic Encephalitis Inactivated Vaccine Market Size in Value by Region (2018-2034)
5.3.1 Global Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value by Region: 2018-2023
5.3.2 Global Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Swine Epidemic Encephalitis Inactivated Vaccine Market Size YoY Growth 2018-2034
6.2 Americas Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Swine Epidemic Encephalitis Inactivated Vaccine Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Swine Epidemic Encephalitis Inactivated Vaccine Market Size YoY Growth 2018-2034
7.2 EMEA Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Swine Epidemic Encephalitis Inactivated Vaccine Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Swine Epidemic Encephalitis Inactivated Vaccine Market Size YoY Growth 2018-2034
8.2 China Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Swine Epidemic Encephalitis Inactivated Vaccine Market Size YoY Growth 2018-2034
9.2 APAC Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Swine Epidemic Encephalitis Inactivated Vaccine Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 KM Biologics
10.1.1 KM Biologics Company Information
10.1.2 KM Biologics Description and Business Overview
10.1.3 KM Biologics Swine Epidemic Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 KM Biologics Swine Epidemic Encephalitis Inactivated Vaccine Products Offered
10.1.5 KM Biologics Recent Development
10.2 Zoetis Animal Health
10.2.1 Zoetis Animal Health Company Information
10.2.2 Zoetis Animal Health Description and Business Overview
10.2.3 Zoetis Animal Health Swine Epidemic Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Zoetis Animal Health Swine Epidemic Encephalitis Inactivated Vaccine Products Offered
10.2.5 Zoetis Animal Health Recent Development
10.3 Boehringer-Ingelheim
10.3.1 Boehringer-Ingelheim Company Information
10.3.2 Boehringer-Ingelheim Description and Business Overview
10.3.3 Boehringer-Ingelheim Swine Epidemic Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Boehringer-Ingelheim Swine Epidemic Encephalitis Inactivated Vaccine Products Offered
10.3.5 Boehringer-Ingelheim Recent Development
10.4 Eurovet
10.4.1 Eurovet Company Information
10.4.2 Eurovet Description and Business Overview
10.4.3 Eurovet Swine Epidemic Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Eurovet Swine Epidemic Encephalitis Inactivated Vaccine Products Offered
10.4.5 Eurovet Recent Development
10.5 Hipra
10.5.1 Hipra Company Information
10.5.2 Hipra Description and Business Overview
10.5.3 Hipra Swine Epidemic Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Hipra Swine Epidemic Encephalitis Inactivated Vaccine Products Offered
10.5.5 Hipra Recent Development
10.6 China Animal Husbandry Industry
10.6.1 China Animal Husbandry Industry Company Information
10.6.2 China Animal Husbandry Industry Description and Business Overview
10.6.3 China Animal Husbandry Industry Swine Epidemic Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 China Animal Husbandry Industry Swine Epidemic Encephalitis Inactivated Vaccine Products Offered
10.6.5 China Animal Husbandry Industry Recent Development
10.7 Inyu Bio-technology
10.7.1 Inyu Bio-technology Company Information
10.7.2 Inyu Bio-technology Description and Business Overview
10.7.3 Inyu Bio-technology Swine Epidemic Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Inyu Bio-technology Swine Epidemic Encephalitis Inactivated Vaccine Products Offered
10.7.5 Inyu Bio-technology Recent Development
10.8 TECON
10.8.1 TECON Company Information
10.8.2 TECON Description and Business Overview
10.8.3 TECON Swine Epidemic Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 TECON Swine Epidemic Encephalitis Inactivated Vaccine Products Offered
10.8.5 TECON Recent Development
10.9 SPAH
10.9.1 SPAH Company Information
10.9.2 SPAH Description and Business Overview
10.9.3 SPAH Swine Epidemic Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 SPAH Swine Epidemic Encephalitis Inactivated Vaccine Products Offered
10.9.5 SPAH Recent Development
10.10 Chongqing Auleon Biologicals
10.10.1 Chongqing Auleon Biologicals Company Information
10.10.2 Chongqing Auleon Biologicals Description and Business Overview
10.10.3 Chongqing Auleon Biologicals Swine Epidemic Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Chongqing Auleon Biologicals Swine Epidemic Encephalitis Inactivated Vaccine Products Offered
10.10.5 Chongqing Auleon Biologicals Recent Development
10.11 Wuhan Keqian Biology
10.11.1 Wuhan Keqian Biology Company Information
10.11.2 Wuhan Keqian Biology Description and Business Overview
10.11.3 Wuhan Keqian Biology Swine Epidemic Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Wuhan Keqian Biology Swine Epidemic Encephalitis Inactivated Vaccine Products Offered
10.11.5 Wuhan Keqian Biology Recent Development
10.12 Hunan Sinoland Bio-Pharmaceutical
10.12.1 Hunan Sinoland Bio-Pharmaceutical Company Information
10.12.2 Hunan Sinoland Bio-Pharmaceutical Description and Business Overview
10.12.3 Hunan Sinoland Bio-Pharmaceutical Swine Epidemic Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Hunan Sinoland Bio-Pharmaceutical Swine Epidemic Encephalitis Inactivated Vaccine Products Offered
10.12.5 Hunan Sinoland Bio-Pharmaceutical Recent Development
10.13 MERRY
10.13.1 MERRY Company Information
10.13.2 MERRY Description and Business Overview
10.13.3 MERRY Swine Epidemic Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.13.4 MERRY Swine Epidemic Encephalitis Inactivated Vaccine Products Offered
10.13.5 MERRY Recent Development
10.14 Shanghai Hile Bio-Technology
10.14.1 Shanghai Hile Bio-Technology Company Information
10.14.2 Shanghai Hile Bio-Technology Description and Business Overview
10.14.3 Shanghai Hile Bio-Technology Swine Epidemic Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Shanghai Hile Bio-Technology Swine Epidemic Encephalitis Inactivated Vaccine Products Offered
10.14.5 Shanghai Hile Bio-Technology Recent Development
10.15 Guangdong Winsun Bio Pharmaceutical
10.15.1 Guangdong Winsun Bio Pharmaceutical Company Information
10.15.2 Guangdong Winsun Bio Pharmaceutical Description and Business Overview
10.15.3 Guangdong Winsun Bio Pharmaceutical Swine Epidemic Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Guangdong Winsun Bio Pharmaceutical Swine Epidemic Encephalitis Inactivated Vaccine Products Offered
10.15.5 Guangdong Winsun Bio Pharmaceutical Recent Development
10.16 Jinhe Biotechnology
10.16.1 Jinhe Biotechnology Company Information
10.16.2 Jinhe Biotechnology Description and Business Overview
10.16.3 Jinhe Biotechnology Swine Epidemic Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Jinhe Biotechnology Swine Epidemic Encephalitis Inactivated Vaccine Products Offered
10.16.5 Jinhe Biotechnology Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Swine Epidemic Encephalitis Inactivated Vaccine Industry Chain Analysis
11.2 Swine Epidemic Encephalitis Inactivated Vaccine Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Swine Epidemic Encephalitis Inactivated Vaccine Production Mode & Process
11.4 Swine Epidemic Encephalitis Inactivated Vaccine Sales and Marketing
11.4.1 Swine Epidemic Encephalitis Inactivated Vaccine Sales Channels
11.4.2 Swine Epidemic Encephalitis Inactivated Vaccine Distributors
11.5 Swine Epidemic Encephalitis Inactivated Vaccine Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Swine Epidemic Encephalitis Inactivated Vaccine CAGR in Value, United States VS Global, 2018 VS 2024 VS 2034
Table 2. Swine Epidemic Encephalitis Inactivated Vaccine Market Trends
Table 3. Swine Epidemic Encephalitis Inactivated Vaccine Market Drivers
Table 4. Swine Epidemic Encephalitis Inactivated Vaccine Market Challenges
Table 5. Swine Epidemic Encephalitis Inactivated Vaccine Market Restraints
Table 6. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Swine Epidemic Encephalitis Inactivated Vaccine Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Swine Epidemic Encephalitis Inactivated Vaccine Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Swine Epidemic Encephalitis Inactivated Vaccine, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Swine Epidemic Encephalitis Inactivated Vaccine Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Swine Epidemic Encephalitis Inactivated Vaccine Revenue Share by Manufacturer, 2018-2023
Table 13. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales by Manufacturer, (K Doses), 2018-2023
Table 14. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Share by Manufacturer, 2018-2023
Table 15. Global Swine Epidemic Encephalitis Inactivated Vaccine Price by Manufacturer (2018-2023) & (US$/Dose)
Table 16. Global Swine Epidemic Encephalitis Inactivated Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Swine Epidemic Encephalitis Inactivated Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Epidemic Encephalitis Inactivated Vaccine as of 2024)
Table 18. Global Key Manufacturers of Swine Epidemic Encephalitis Inactivated Vaccine, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Swine Epidemic Encephalitis Inactivated Vaccine, Product Offered and Application
Table 20. Global Key Manufacturers of Swine Epidemic Encephalitis Inactivated Vaccine, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Swine Epidemic Encephalitis Inactivated Vaccine in United States, Ranked by Revenue (2024) & (US$ million)
Table 23. United States Swine Epidemic Encephalitis Inactivated Vaccine Revenue by Players, (US$ Million), (2018-2023)
Table 24. United States Swine Epidemic Encephalitis Inactivated Vaccine Revenue Share by Players, (2018-2023)
Table 25. United States Swine Epidemic Encephalitis Inactivated Vaccine Sales by Players, (K Doses), (2018-2023)
Table 26. United States Swine Epidemic Encephalitis Inactivated Vaccine Sales Share by Players, (2018-2023)
Table 27. Global Swine Epidemic Encephalitis Inactivated Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume by Region (2018-2023) & (K Doses)
Table 29. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume Forecast by Region (2024-2034) & (K Doses)
Table 30. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Swine Epidemic Encephalitis Inactivated Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume by Country (2018-2023) & (K Doses)
Table 36. Americas Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume by Country (2024-2034) & (K Doses)
Table 37. EMEA Swine Epidemic Encephalitis Inactivated Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume by Country (2018-2023) & (K Doses)
Table 41. EMEA Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume by Country (2024-2034) & (K Doses)
Table 42. APAC Swine Epidemic Encephalitis Inactivated Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume by Country (2018-2023) & (K Doses)
Table 46. APAC Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume by Country (2024-2034) & (K Doses)
Table 47. KM Biologics Company Information
Table 48. KM Biologics Description and Business Overview
Table 49. KM Biologics Swine Epidemic Encephalitis Inactivated Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 50. KM Biologics Swine Epidemic Encephalitis Inactivated Vaccine Product
Table 51. KM Biologics Recent Development
Table 52. Zoetis Animal Health Company Information
Table 53. Zoetis Animal Health Description and Business Overview
Table 54. Zoetis Animal Health Swine Epidemic Encephalitis Inactivated Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 55. Zoetis Animal Health Swine Epidemic Encephalitis Inactivated Vaccine Product
Table 56. Zoetis Animal Health Recent Development
Table 57. Boehringer-Ingelheim Company Information
Table 58. Boehringer-Ingelheim Description and Business Overview
Table 59. Boehringer-Ingelheim Swine Epidemic Encephalitis Inactivated Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 60. Boehringer-Ingelheim Swine Epidemic Encephalitis Inactivated Vaccine Product
Table 61. Boehringer-Ingelheim Recent Development
Table 62. Eurovet Company Information
Table 63. Eurovet Description and Business Overview
Table 64. Eurovet Swine Epidemic Encephalitis Inactivated Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 65. Eurovet Swine Epidemic Encephalitis Inactivated Vaccine Product
Table 66. Eurovet Recent Development
Table 67. Hipra Company Information
Table 68. Hipra Description and Business Overview
Table 69. Hipra Swine Epidemic Encephalitis Inactivated Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 70. Hipra Swine Epidemic Encephalitis Inactivated Vaccine Product
Table 71. Hipra Recent Development
Table 72. China Animal Husbandry Industry Company Information
Table 73. China Animal Husbandry Industry Description and Business Overview
Table 74. China Animal Husbandry Industry Swine Epidemic Encephalitis Inactivated Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 75. China Animal Husbandry Industry Swine Epidemic Encephalitis Inactivated Vaccine Product
Table 76. China Animal Husbandry Industry Recent Development
Table 77. Inyu Bio-technology Company Information
Table 78. Inyu Bio-technology Description and Business Overview
Table 79. Inyu Bio-technology Swine Epidemic Encephalitis Inactivated Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 80. Inyu Bio-technology Swine Epidemic Encephalitis Inactivated Vaccine Product
Table 81. Inyu Bio-technology Recent Development
Table 82. TECON Company Information
Table 83. TECON Description and Business Overview
Table 84. TECON Swine Epidemic Encephalitis Inactivated Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 85. TECON Swine Epidemic Encephalitis Inactivated Vaccine Product
Table 86. TECON Recent Development
Table 87. SPAH Company Information
Table 88. SPAH Description and Business Overview
Table 89. SPAH Swine Epidemic Encephalitis Inactivated Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 90. SPAH Swine Epidemic Encephalitis Inactivated Vaccine Product
Table 91. SPAH Recent Development
Table 92. Chongqing Auleon Biologicals Company Information
Table 93. Chongqing Auleon Biologicals Description and Business Overview
Table 94. Chongqing Auleon Biologicals Swine Epidemic Encephalitis Inactivated Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 95. Chongqing Auleon Biologicals Swine Epidemic Encephalitis Inactivated Vaccine Product
Table 96. Chongqing Auleon Biologicals Recent Development
Table 97. Wuhan Keqian Biology Company Information
Table 98. Wuhan Keqian Biology Description and Business Overview
Table 99. Wuhan Keqian Biology Swine Epidemic Encephalitis Inactivated Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 100. Wuhan Keqian Biology Swine Epidemic Encephalitis Inactivated Vaccine Product
Table 101. Wuhan Keqian Biology Recent Development
Table 102. Hunan Sinoland Bio-Pharmaceutical Company Information
Table 103. Hunan Sinoland Bio-Pharmaceutical Description and Business Overview
Table 104. Hunan Sinoland Bio-Pharmaceutical Swine Epidemic Encephalitis Inactivated Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 105. Hunan Sinoland Bio-Pharmaceutical Swine Epidemic Encephalitis Inactivated Vaccine Product
Table 106. Hunan Sinoland Bio-Pharmaceutical Recent Development
Table 107. MERRY Company Information
Table 108. MERRY Description and Business Overview
Table 109. MERRY Swine Epidemic Encephalitis Inactivated Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 110. MERRY Swine Epidemic Encephalitis Inactivated Vaccine Product
Table 111. MERRY Recent Development
Table 112. Shanghai Hile Bio-Technology Company Information
Table 113. Shanghai Hile Bio-Technology Description and Business Overview
Table 114. Shanghai Hile Bio-Technology Swine Epidemic Encephalitis Inactivated Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 115. Shanghai Hile Bio-Technology Swine Epidemic Encephalitis Inactivated Vaccine Product
Table 116. Shanghai Hile Bio-Technology Recent Development
Table 117. Guangdong Winsun Bio Pharmaceutical Company Information
Table 118. Guangdong Winsun Bio Pharmaceutical Description and Business Overview
Table 119. Guangdong Winsun Bio Pharmaceutical Swine Epidemic Encephalitis Inactivated Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 120. Guangdong Winsun Bio Pharmaceutical Swine Epidemic Encephalitis Inactivated Vaccine Product
Table 121. Guangdong Winsun Bio Pharmaceutical Recent Development
Table 122. Jinhe Biotechnology Company Information
Table 123. Jinhe Biotechnology Description and Business Overview
Table 124. Jinhe Biotechnology Swine Epidemic Encephalitis Inactivated Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 125. Jinhe Biotechnology Swine Epidemic Encephalitis Inactivated Vaccine Product
Table 126. Jinhe Biotechnology Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Swine Epidemic Encephalitis Inactivated Vaccine Customers List
Table 130. Swine Epidemic Encephalitis Inactivated Vaccine Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Swine Epidemic Encephalitis Inactivated Vaccine Product Picture
Figure 2. Global Swine Epidemic Encephalitis Inactivated Vaccine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Swine Epidemic Encephalitis Inactivated Vaccine Market Size 2018-2034 (US$ Million)
Figure 4. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales 2018-2034 (K Doses)
Figure 5. United States Swine Epidemic Encephalitis Inactivated Vaccine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. United States Swine Epidemic Encephalitis Inactivated Vaccine Market Size 2018-2034 (US$ Million)
Figure 7. United States Swine Epidemic Encephalitis Inactivated Vaccine Sales 2018-2034 (K Doses)
Figure 8. United States Swine Epidemic Encephalitis Inactivated Vaccine Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. United States Swine Epidemic Encephalitis Inactivated Vaccine Market Share in Global, in Volume (K Doses) 2018-2034
Figure 10. Swine Epidemic Encephalitis Inactivated Vaccine Report Years Considered
Figure 11. Product Picture of Mouse Brain Inactivated Vaccine
Figure 12. Product Picture of Cell Culture Inactivated Vaccine
Figure 13. Product Picture of Cell Culture Live Attenuated Vaccine
Figure 14. Product Picture of Genetically Engineered Live Attenuated Vaccine
Figure 15. Global Swine Epidemic Encephalitis Inactivated Vaccine Market Share by Type in 2024 & 2034
Figure 16. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value by Type (2018-2034) & (US$ Million)
Figure 17. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Market Share in Value by Type (2018-2034)
Figure 18. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales by Type (2018-2034) & (K Doses)
Figure 19. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 20. Global Swine Epidemic Encephalitis Inactivated Vaccine Price by Type (2018-2034) & (US$/Dose)
Figure 21. United States Swine Epidemic Encephalitis Inactivated Vaccine Market Share by Type in 2024 & 2034
Figure 22. United States Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value by Type (2018-2034) & (US$ Million)
Figure 23. United States Swine Epidemic Encephalitis Inactivated Vaccine Sales Market Share in Value by Type (2018-2034)
Figure 24. United States Swine Epidemic Encephalitis Inactivated Vaccine Sales by Type (2018-2034) & (K Doses)
Figure 25. United States Swine Epidemic Encephalitis Inactivated Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 26. United States Swine Epidemic Encephalitis Inactivated Vaccine Price by Type (2018-2034) & (US$/Dose)
Figure 27. Product Picture of Piglets
Figure 28. Product Picture of Adults Pigs
Figure 29. Global Swine Epidemic Encephalitis Inactivated Vaccine Market Share by Application in 2024 & 2034
Figure 30. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value by Application (2018-2034) & (US$ Million)
Figure 31. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Market Share in Value by Application (2018-2034)
Figure 32. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales by Application (2018-2034) & (K Doses)
Figure 33. Global Swine Epidemic Encephalitis Inactivated Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 34. Global Swine Epidemic Encephalitis Inactivated Vaccine Price by Application (2018-2034) & (US$/Dose)
Figure 35. United States Swine Epidemic Encephalitis Inactivated Vaccine Market Share by Application in 2024 & 2034
Figure 36. United States Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value by Application (2018-2034) & (US$ Million)
Figure 37. United States Swine Epidemic Encephalitis Inactivated Vaccine Sales Market Share in Value by Application (2018-2034)
Figure 38. United States Swine Epidemic Encephalitis Inactivated Vaccine Sales by Application (2018-2034) & (K Doses)
Figure 39. United States Swine Epidemic Encephalitis Inactivated Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 40. United States Swine Epidemic Encephalitis Inactivated Vaccine Price by Application (2018-2034) & (US$/Dose)
Figure 41. Americas Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume Growth Rate 2018-2034 (K Doses)
Figure 42. Americas Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 43. Americas Swine Epidemic Encephalitis Inactivated Vaccine Sales by Type (2018-2034) & (K Doses)
Figure 44. Americas Swine Epidemic Encephalitis Inactivated Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 45. Americas Swine Epidemic Encephalitis Inactivated Vaccine Sales by Application (2018-2034) & (K Doses)
Figure 46. Americas Swine Epidemic Encephalitis Inactivated Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 47. United States Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 48. Canada Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 49. Mexico Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. Brazil Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 51. EMEA Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume Growth Rate 2018-2034 (K Doses)
Figure 52. EMEA Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 53. EMEA Swine Epidemic Encephalitis Inactivated Vaccine Sales by Type (2018-2034) & (K Doses)
Figure 54. EMEA Swine Epidemic Encephalitis Inactivated Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 55. EMEA Swine Epidemic Encephalitis Inactivated Vaccine Sales by Application (2018-2034) & (K Doses)
Figure 56. EMEA Swine Epidemic Encephalitis Inactivated Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 57. Europe Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 58. Middle East Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 59. Africa Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 60. China Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume Growth Rate 2018-2034 (K Doses)
Figure 61. China Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 62. China Swine Epidemic Encephalitis Inactivated Vaccine Sales by Type (2018-2034) & (K Doses)
Figure 63. China Swine Epidemic Encephalitis Inactivated Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 64. China Swine Epidemic Encephalitis Inactivated Vaccine Sales by Application (2018-2034) & (K Doses)
Figure 65. China Swine Epidemic Encephalitis Inactivated Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 66. APAC Swine Epidemic Encephalitis Inactivated Vaccine Sales in Volume Growth Rate 2018-2034 (K Doses)
Figure 67. APAC Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 68. APAC Swine Epidemic Encephalitis Inactivated Vaccine Sales by Type (2018-2034) & (K Doses)
Figure 69. APAC Swine Epidemic Encephalitis Inactivated Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 70. APAC Swine Epidemic Encephalitis Inactivated Vaccine Sales by Application (2018-2034) & (K Doses)
Figure 71. APAC Swine Epidemic Encephalitis Inactivated Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 72. Japan Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 73. South Korea Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 74. China Taiwan Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. India Swine Epidemic Encephalitis Inactivated Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 77. Swine Epidemic Encephalitis Inactivated Vaccine Value Chain
Figure 78. Swine Epidemic Encephalitis Inactivated Vaccine Production Process
Figure 79. Channels of Distribution
Figure 80. Distributors Profiles
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed